ArticleBMC cancer2019

Concomitant use of pembrolizumab and entinostat in adult patients with metastatic uveal melanoma (PEMDAC study): protocol for a multicenter phase II open label study.

Henrik Jespersen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.